Impacted maxillary canine

K11_MAXIL_CANINE_FAILED_ERUPT_OBSTRUCTION_TOOTH

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Primary healthcare outpatient: ICD-10 — K01.12 Hospital discharge: ICD-10 — K01.12 Cause of death: ICD-10 — K01.12 3 out of 7 registries used, show all original rules.	346
4. Check minimum number of events None	346
5. Include endpoints None	346
6. Filter based on genotype QC (FinnGen only)	326

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF7

NAME	K11_MAXIL_CANINE_FAILED_ERUPT_OBSTRUCTION_TOOTH
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD	K0112
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	K0112
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	K0112
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Impacted maxillary canine based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	11074	6671	4385
Only index persons	10022	6005	4017
Unadjusted period prevalence (%)
Whole population	0.16	0.19	0.12
Only index persons	0.19	0.22	0.15
Median age at first event (years)
Whole population	12.51	12.38	12.64
Only index persons	12.80	12.73	12.90

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	326	233	93
Unadjusted period prevalence (%)	0.07	0.08	0.04
Median age at first event (years)	14.84	14.50	15.68

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
346: Matched controls
3460

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

K01.12

ICD-10 Finland

Retained canine with obstruction in the upper jaw

+∞

307.7

346

ECA00

NOMESCO Finland

Surgical exposure of tooth

86.2

226.7

123

SJD10

NOMESCO Finland

Placement of orthodontic arch wire

7.1

71.2

157

363

SJD00

NOMESCO Finland

Removal and/or reactivation of orthodontic arch wire

7.0

70.1

154

354

K07.35

ICD-10 Finland

Impacted or embedded teeth with abnormal position of such teeth or adjacent teeth

14.4

55.1

SJC01

NOMESCO Finland

Positioning and fixed attachment of single bracket (Bracket with fixed attachment)

6.0

54.2

131

320

SJD20

NOMESCO Finland

Placement of modified orthodontic arch wire

6.3

53.5

115

252

K01.0

ICD-10 Finland

Embedded teeth

9.1

48.0

SJC50

NOMESCO Finland

Removal of fixed orthodontic appliance with at least 7 brackets

5.2

44.1

120

319

SJC03

NOMESCO Finland

Positioning and fixed attachment of brackets, extensive

5.5

43.1

106

258

SBB10

NOMESCO Finland

Dental impressions

4.3

39.9

180

698

SJB00

NOMESCO Finland

Fitting of removable appliance incl. patient instructions

4.6

38.7

128

393

SJD40

NOMESCO Finland

Placement of prefabricated palatal or lingual arch

4.4

36.5

125

392

SJC02

NOMESCO Finland

Positioning and fixed attachment of brackets

4.9

30.7

205

SXC05

NOMESCO Finland

Other oral or dental procedure

3.6

29.2

140

544

SJD30

NOMESCO Finland

Demanding placement of orthodontic arch wire

5.2

28.8

156

SAA04

NOMESCO Finland

Special examination of mouth

4.0

28.3

103

331

EBA12

NOMESCO Finland

Demanding operative extraction of tooth

6.2

27.4

SXB00

NOMESCO Finland

Removal of sutures from oral mucosa

5.8

26.9

107

EB1AI

NOMESCO Finland

Cone beam imaging of teeth and jaws (one quarter)

11.2

25.7

SJX21

NOMESCO Finland

Therapeutic intervention or check-up related to orthodontic treatment

3.6

23.6

335

SJC10

NOMESCO Finland

Orthodontic band in one tooth

3.7

23.0

300

SJX11

NOMESCO Finland

Therapeutic intervention or check-up related to orthodontic treatment, restricted

3.2

21.4

115

466

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

3.5

19.6

267

EBA00

NOMESCO Finland

Extraction of tooth

2.8

19.2

221

1328

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.8

18.5

232

1446

EB1MA

NOMESCO Finland

Cephalometry with X-ray

3.3

18.3

307

K07.30

ICD-10 Finland

Spacing, abnormal of tooth or teeth

3.1

18.1

388

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

4.7

16.5

SAA03

NOMESCO Finland

Extended examination of mouth

2.7

15.4

255

1751

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

3.0

15.4

306

SJX10

NOMESCO Finland

Orthodontic treatment/control appointment, short

2.6

14.4

109

516

SJD50

NOMESCO Finland

Placement of prefabricated palatal or lingual arch, dentist-made

5.1

13.8

SAC02

NOMESCO Finland

Separate planning of oral and dental treatment, demanding

3.1

12.4

200

K01.13

ICD-10 Finland

Retained canine with obstruction in the lower jaw

39.1

12.3

OIKAL, ,

NOMESCO Finland

3.6

12.2

131

K00.00

ICD-10 Finland

Hypodontia

4.2

11.8

WX110

NOMESCO Finland

Infiltration anesthesia

2.8

11.2

295

2323

K07.25

ICD-10 Finland

Anomalies of dental arch relationship

2.9

10.3

203

SJC40

NOMESCO Finland

Removal of fixed orthodontic appliance with at most 6 brackets

2.4

10.1

387

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

2.1

9.9

186

1247

EBA10

NOMESCO Finland

Operative extraction of tooth

2.2

9.6

104

565

OIKK, ,

NOMESCO Finland

2.3

9.5

404

EB1AD

NOMESCO Finland

Cone beam CT of teeth and jaws (one quarter)

102.7

9.5

OIKH, ,

NOMESCO Finland

2.5

9.2

293

SJC00

NOMESCO Finland

Bondable bracket or other fixed attachement

24.8

9.0

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

2.0

8.7

190

1323

WZA90

NOMESCO Finland

Other medical or dental certificate

2.0

8.5

139

874

WZC00

NOMESCO Finland

Treatment plan or consultation

1.9

8.1

184

1288

K00.68

ICD-10 Finland

Other disturbance in the tooth eruption

3.0

7.9

134

SAC01

NOMESCO Finland

Separate planning of oral and dental treatment, standard

2.4

7.7

254

K07.23

ICD-10 Finland

Deep bite

2.4

7.7

282

SJX20

NOMESCO Finland

Orthodontic treatment/control appointment

2.3

7.7

296

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.9

7.6

123

765

K01.19

ICD-10 Finland

Retained tooth with obstruction barrier UNS

30.7

7.2

EMAK, ,

NOMESCO Finland

3.8

6.6

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

3.1

6.5

EBB10

NOMESCO Finland

Insertion of dental implant

11.3

6.3

K07.13

ICD-10 Finland

Retrognaty, mandibular

3.4

6.2

K01.14

ICD-10 Finland

Retained premolar with obstruction in the upper jaw

12.8

6.1

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

6.9

6.1

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3019150) Specific gravity of Urine by Refractometry

617

1.72

4.53

4.6

3.2

1.01

1.02

kg/l

0.47

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

133

959

1.63

4.46

4.6

3.4

—

(40761535) Cells panel - Urine sediment

152

2.29

4.41

3.6

3.4

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

149

1124

1.57

4.05

8.6

9.1

1.21

1.22

mmol/l

0.66

132

997

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

666

1.61

3.66

3.1

2.5

96.46

55.17

u/l

0.75

608

(3019060) Gas panel - Arterial blood

2.62

3.52

3.0

10.4

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

110

2.27

3.27

1.5

1.3

—

(1761482) Bacteria [#/volume] in Urine by Culture

2.88

3.12

2.9

3.7

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

582

1.56

2.97

3.4

3.1

23.95

30.06

ng/l

0.29

287

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

3.65

2.80

1.9

1.8

—

(3015736) pH of Urine

136

1069

1.45

2.78

3.8

3.1

6.19

5.99

—

(3027801) Oxygen [Partial pressure] in Arterial blood

176

1.90

2.75

9.5

11.8

14.63

14.47

kpa

0.05

171

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

176

1.90

2.75

9.4

11.9

5.13

5.10

kpa

0.05

170

(3003396) Base excess in Arterial blood by calculation

178

1.88

2.66

9.4

11.8

0.50

0.64

mmol/l

0.07

148

(40768441) Liver Pathology biopsy report

4.07

2.58

1.7

1.6

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

3.87

2.47

1.1

1.2

91.88

110.19

—

(3041096) Erythrocytes [Presence] in Urine by Automated

723

1.45

2.41

4.1

3.0

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

147

1.91

2.41

1.0

1.1

4.04

8.70

u/ml

1.57

103

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

3.09

2.37

2.0

1.7

—

(3000330) Specific gravity of Urine by Test strip

112

2.03

2.36

2.9

2.8

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

3.27

2.32

2.6

1.5

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

3.95

2.26

1.1

1.6

—

(3020891) Body temperature

2.39

2.25

2.4

5.0

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

145

1.86

2.17

1.0

1.1

1.58

1.32

u/ml

0.07

(3002032) Base excess in Venous blood by calculation

420

1.52

2.15

8.9

7.9

1.35

1.25

mmol/l

0.07

343

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

3.55

2.06

1.0

1.4

132.43

125.55

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

148

0.33

2.05

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

148

0.33

2.05

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

148

0.33

2.05

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

148

0.33

2.05

1.4

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

4.05

2.04

3.2

1.5

—

(3035637) Corticotropin [Mass/volume] in Plasma

2.27

2.03

1.9

1.7

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

2.68

2.02

2.8

1.6

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

2.68

2.02

2.8

1.6

—

(3035350) Ketones [Presence] in Urine by Test strip

155

1301

1.35

1.99

4.7

3.4

0.00

estimate

0.50

294

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

2.61

1.95

2.3

1.4

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

167

1.74

1.90

1.1

1.2

5.00

4.67

u/ml

0.04

109

(1761868) Lipid panel - Serum or Plasma

716

1.39

1.89

2.5

2.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

3.23

1.89

2.9

2.4

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

2.69

1.88

1.4

1.7

—

(3016244) Insulin [Units/volume] in Serum or Plasma

2.17

1.84

2.7

3.2

19.14

30.71

mu/l

0.40

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

2.38

1.79

4.6

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

2.38

1.79

4.6

1.6

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

461

0.62

1.76

3.6

3.4

2.97

4.15

e6/l

0.47

251

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

177

0.44

1.75

1.5

—

(3021601) Nitrite [Presence] in Urine by Test strip

152

1294

1.31

1.70

6.3

4.7

0.00

estimate

-0.00

290

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

2.84

1.66

2.9

1.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

2.48

1.65

2.0

1.7

—

(3009261) Glucose [Presence] in Urine by Test strip

153

1308

1.30

1.65

4.7

3.5

0.00

estimate

-0.00

284

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

3.03

1.58

1.2

1.6

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

197

1754

1.29

1.51

4.2

37.14

38.06

mmol/mol

0.68

187

1640

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

339

1.45

1.48

1.9

1.6

455.02

22789552.44

pmol/l

0.50

294

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

374

1.43

1.47

3.5

4.4

964.43

882.31

ng/l

0.07

313

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

297

1.47

1.46

2.7

2.9

17.90

23.20

1.83

270

(3000492) Spirometry study

230

1.53

1.46

1.6

1.5

—

(3042936) Bacteria identified in Isolate by Culture

289

1.47

1.45

2.2

1.9

—

(3029937) Albumin [Presence] in Urine by Test strip

708

1.33

1.45

5.2

3.6

0.00

estimate

0.50

285

(3007853) Bacteria identified in Skin by Aerobe culture

315

1.45

1.44

1.7

1.6

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

104

858

1.30

1.43

4.9

6.0

36.95

37.43

g/l

0.40

810

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

2.21

1.41

2.0

1.6

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

126

1068

1.28

1.40

8.9

6.4

8.61

10.14

umol/l

2.40

114

981

(3014576) Chloride [Moles/volume] in Serum or Plasma

249

1.50

1.40

7.4

8.7

105.92

104.60

mmol/l

1.68

249

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

2.44

1.40

1.0

1.3

—

(3002179) Metamyelocytes/100 leukocytes in Blood

176

1.58

1.36

3.4

5.4

0.57

0.75

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

161

1414

1.26

1.32

7.8

5.6

6.28

6.34

mmol/l

0.14

146

1282

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

321

1.42

1.32

2.6

1.8

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

2.80

1.29

1.4

1.1

—

(40761536) Microorganisms panel - Urine sediment

264

0.59

1.27

4.5

3.5

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

2.07

1.27

1.0

1.2

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

473

0.69

1.26

3.1

3.2

1.94

1.14

e6/l

0.41

258

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

131

1129

1.26

1.25

2.6

2.8

—

(3018133) Calcium [Moles/volume] in Urine

2.25

1.25

4.9

3.1

2.81

2.08

mmol/l

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

205

1.51

1.25

5.3

5.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

2.03

1.24

2.7

1.2

—

(3017181) Myelocytes/100 leukocytes in Blood

189

1.52

1.23

3.4

5.8

0.43

0.87

—

(4094501) Cardiovascular stress test using bicycle ergometer

2.19

1.22

1.0

1.1

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

495

1.33

1.22

3.9

3.0

2.34

1.15

mg/l

0.44

349

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

122

1046

1.26

1.21

9.8

9.0

1.21

1.22

mmol/l

0.46

115

986

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1.96

1.18

4.5

2.3

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

110

1.67

1.18

2.2

3.1

0.68

0.17

e6/l

0.70

105

(3003458) Phosphate [Moles/volume] in Serum or Plasma

426

1.35

1.17

13.0

9.4

1.25

1.22

mmol/l

0.30

406

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.52

1.15

1.2

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1.78

1.14

2.4

1.8

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

1.97

1.09

1.3

1.2

7.20

6.41

g/l

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

1.97

1.09

1.3

1.2

2.36

2.77

g/l

—

(4062490) Immunoglobulin typing, IgG

1.97

1.09

1.3

1.2

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

1.97

1.09

1.3

1.2

0.51

0.41

g/l

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.40

1.09

1.2

1.1

—

(44813793) Dust mix specific IgE antibody measurement

2.21

1.08

1.0

1.1

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

129

1.58

1.08

2.1

1.8

—

(3000494) Fungus identified in Specimen by Culture

247

1.42

1.06

1.7

1.8

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1.70

1.06

1.6

2.2

0.63

0.57

nmol/l

0.11

(3023511) Choriogonadotropin [Units/volume] in Urine

205

1.45

1.05

1.7

1.3

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1.98

1.04

3.6

2.7

—

(3000991) Gas panel - Venous blood

372

1.34

1.03

13.1

9.9

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

390

1.33

1.03

4.5

4.1

29.79

30.00

0.11

383

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

272

0.64

1.02

1.2

1.9

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

337

1.35

1.02

1.7

2.3

24865.00

6866.32

u/l

0.48

118

(3045414) Leukocytes [Presence] in Urine

110

0.45

1.02

1.8

1.6

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

311

1.36

1.01

1.0

1.1

—

(3044889) 12 lead EKG panel

123

1392

0.82

0.99

3.0

2.9

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

204

1876

1.21

0.99

3.1

1.25

1.18

mmol/l

0.66

192

1767

(3026008) Bacteria identified in Urine by Culture

791

1.24

0.98

2.8

2.6

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1.77

0.97

2.8

1.7

—

(3021901) Oxygen saturation in Capillary blood

1.78

0.95

1.9

3.5

—

(3013512) EKG study

477

1.29

0.95

3.5

3.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1.91

0.94

1.1

1.0

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1.74

0.93

3.7

1.9

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

939

0.81

0.91

2.2

2.6

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

229

1.39

0.90

1.9

1.8

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

1.88

0.88

3.9

3.5

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

753

1.23

0.88

1.5

1.6

94.22

97.30

pmol/l

0.26

382

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1.76

0.83

1.6

1.4

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

887

0.82

2.1

2.4

—

(3021960) Folate [Moles/volume] in Serum or Plasma

441

1.27

0.81

1.3

1.4

17.98

19.20

nmol/l

0.29

377

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

0.00

0.79

0.0

1.4

—

(3011648) Oxygen content in Venous blood

1.78

0.76

7.8

17.3

11.90

12.14

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1.66

0.76

4.6

1.6

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1.62

0.76

4.3

2.0

—

(3008898) HLA-B27 [Presence]

159

0.62

0.74

1.0

1.1

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

290

2794

1.23

0.72

14.5

10.7

20.14

21.40

mg/l

0.27

221

1980

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1.60

0.72

1.3

—

(3007164) IgA [Mass/volume] in Serum or Plasma

111

989

1.18

0.72

1.5

1.6

1.87

1.84

g/l

0.07

540

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1.77

0.71

1.6

1.5

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

186

1728

1.17

0.71

8.0

6.0

89.00

91.67

u/l

0.27

175

1614

(36304419) Bacteria [Presence] in Urine

759

0.82

0.70

3.3

3.6

—

(3003694) ABO and Rh group [Type] in Blood

108

963

1.18

0.69

1.5

1.7

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

122

1099

1.17

0.69

1.6

1.7

1.32

2.22

u/ml

0.75

246

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

1.86

0.68

6.4

5.4

0.58

1.34

ug/l

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

162

1.38

0.68

1.8

1.7

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

279

0.74

0.64

1.4

—

(36660697) Celiac disease serology panel - Serum

408

1.23

0.64

1.2

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

1.73

0.64

1.6

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

1.68

0.61

1.2

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

1.68

0.61

1.2

1.5

—

(21494755) Public health laboratory ask at order entry panel

219

1.30

0.61

1.1

1.2

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.60

0.0

1.6

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

0.00

0.60

0.0

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

292

1.26

0.60

1.6

1.3

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

232

2208

1.15

0.59

4.2

3.7

14.49

14.47

pmol/l

0.05

207

1986

(3021589) Normoblasts [#/volume] in Blood

153

1417

1.14

0.58

10.7

9.7

0.00

e9/l

0.49

125

1117

(3019230) Fractional oxyhemoglobin in Venous blood

1.47

0.56

6.6

12.5

66.75

67.64

—

(40768797) Stomach Pathology biopsy report

260

0.76

0.55

1.1

1.3

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

1.50

0.54

1.0

1.1

0.04

0.60

u/ml

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

336

0.79

0.54

1.6

1.5

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

1.55

0.53

1.2

1.1

—

(3022621) pH of Urine by Test strip

161

1.32

0.53

7.0

2.3

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

179

1.31

0.53

18.7

15.8

1.30

1.10

mg/l

0.64

174

(3024928) Oxygen saturation in Venous blood

1.44

0.52

7.0

11.6

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

144

1.34

0.52

1.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

256

2649

0.87

0.50

3.8

3.7

—

(3001604) Monocytes [#/volume] in Blood

159

1488

1.13

0.50

10.5

7.5

0.53

0.54

e9/l

0.21

135

1277

(3018095) Leukocytes [#/volume] in Urine

983

0.87

0.50

4.1

4.4

466.56

78.75

e6/l

0.48

652

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

1.44

0.50

1.4

1.1

—

(3013115) Eosinophils [#/volume] in Blood

163

1528

1.13

0.50

11.0

7.9

0.19

0.18

e9/l

0.07

140

1335

(3026782) Osmolality of Urine

534

1.17

0.50

2.6

3.3

583.18

587.02

mosm/kgh2o

0.04

454

(3019198) Lymphocytes [#/volume] in Blood

166

1558

1.13

0.49

10.1

7.4

2.04

2.02

e9/l

0.11

146

1378

(46235355) HIV 1 and 2 tests - Meaningful Use set

992

0.87

0.49

2.0

2.1

—

(3047181) Lactate [Moles/volume] in Blood

1.50

0.48

4.1

15.3

1.23

1.08

mmol/l

—

(3003327) Ova and parasites identified in Stool by Light microscopy

142

0.70

0.47

1.4

1.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

228

1.25

0.47

1.7

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1.44

0.46

1.0

1.2

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

103

1.37

0.46

17.9

11.6

24.00

24.17

mmol/l

0.06

103

(3006315) Basophils [#/volume] in Blood

158

1485

1.12

0.45

10.5

7.5

0.04

e9/l

0.64

136

1270

(3002582) Erythrocytes [#/volume] in Urine

822

0.87

0.45

3.4

3.8

42.95

51.61

e6/l

0.11

615

(3034770) Mitochondria Ab [Titer] in Serum

1.46

0.44

1.3

1.8

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1.38

0.44

18.0

15.8

—

(3009542) Hematocrit [Volume Fraction] of Blood

313

3183

0.83

0.43

21.3

15.9

38.74

40.01

2.17

290

3013

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

140

1.30

0.43

1.3

1.4

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

149

1.29

0.43

8.3

6.4

96.47

94.73

0.15

149

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.57

0.42

1.0

1.3

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

1.57

0.42

1.2

1.1

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

1.57

0.42

1.2

1.1

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

164

1550

1.11

0.42

5.1

3.5

31.75

32.23

u/l

0.05

152

1477

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

0.00

0.41

0.0

4.3

—

9.39

—

(3020876) Protein [Mass/time] in 24 hour Urine

0.00

0.41

0.0

2.5

—

2.53

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.7

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.7

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

344

1.18

0.41

9.2

8.6

23.95

23.58

mmol/l

0.27

344

(4146454) Self-monitoring of blood glucose

0.00

0.40

0.0

2.8

—

(3011288) Drugs identified in Urine by Screen method

248

0.79

0.40

1.3

2.0

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

0.00

0.40

0.0

1.0

—

113.11

—

(3000093) Morphology [Interpretation] in Blood Narrative

1.43

0.39

1.0

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

1.43

0.39

1.4

1.7

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

151

1.27

0.39

1.6

1.5

—

(3019225) pH of Specimen

152

1.26

0.38

1.5

4.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

342

0.83

0.38

1.6

1.5

—

(3000963) Hemoglobin [Mass/volume] in Blood

314

3188

0.84

0.38

21.2

15.7

133.01

134.40

g/l

1.08

308

3134

(3010813) Leukocytes [#/volume] in Blood

314

3187

0.84

0.36

20.6

15.6

6.81

6.64

e9/l

0.82

301

3070

(3012095) Magnesium [Moles/volume] in Serum or Plasma

358

1.16

0.36

13.9

8.2

0.82

0.81

mmol/l

0.35

339

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

0.64

0.36

2.2

1.7

0.19

0.30

nmol/l

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

123

0.72

0.36

3.2

1.7

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1.44

0.35

1.2

1.3

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.62

0.35

1.0

1.5

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

156

0.76

0.35

2.2

1.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

686

1.12

0.34

1.8

1.6

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

725

1.12

0.34

2.6

2.7

2.86

2.73

mg/l

0.18

630

(4035726) Immunohistochemistry procedure

144

0.76

0.34

1.5

1.6

—

(40758558) Short blood count panel - Blood

775

0.89

0.33

8.4

7.5

—

(40768443) Skin Pathology biopsy report

0.69

0.33

1.0

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

187

0.79

0.33

1.7

1.9

—

(3019309) Folate [Moles/volume] in Red Blood Cells

267

1.18

0.32

1.5

1.7

1293.04

1091.67

nmol/l

0.53

199

(3022217) INR in Platelet poor plasma by Coagulation assay

777

1.11

0.32

12.9

7.7

1.35

1.12

inr

0.95

265

(3025018) Bordetella pertussis Ab [Titer] in Serum

1.33

0.31

1.6

1.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

196

0.81

0.31

3.9

4.6

17.50

21.06

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

208

2009

1.09

0.30

3.5

3.6

2.72

2.69

mmol/l

0.21

196

1879

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1.30

0.30

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1.30

0.30

1.4

1.3

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

1.28

0.30

1.9

1.7

—

(3048689) Calprotectin [Mass/mass] in Stool

518

1.12

0.30

2.2

2.9

142.92

83.14

ug/g

0.47

384

(3023368) Bacteria identified in Blood by Culture

472

1.12

0.28

5.2

4.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

225

0.84

0.27

1.2

1.8

—

(3033658) Prothrombin time (PT) actual/Normal

642

0.90

0.27

8.1

5.5

87.32

89.70

0.35

633

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1.29

0.26

1.4

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

455

0.89

0.26

1.4

—

(40768804) Tissue Pathology biopsy report

764

0.91

0.26

1.5

1.8

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

1.22

0.25

1.6

1.1

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

174

1679

1.07

0.24

11.3

9.5

3.72

3.75

e9/l

0.07

148

1440

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

180

1.18

0.24

2.6

1.8

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

1.32

0.23

1.6

2.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

667

0.91

0.23

1.6

1.8

—

(3037467) Urinalysis macro (dipstick) panel - Urine

186

1802

1.07

0.23

4.9

4.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1.25

0.23

1.1

1.4

—

(3026361) Erythrocytes [#/volume] in Blood

315

3184

0.88

0.23

20.5

15.5

4.53

4.57

e12/l

0.98

303

3069

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

204

1983

1.07

0.23

3.4

3.3

1.42

1.45

mmol/l

0.76

193

1865

(21494815) CD4 cells/100 lymphocytes in Specimen

1.29

0.23

5.0

3.6

40.14

34.64

—

(3028271) Lactate [Moles/volume] in Capillary blood

1.29

0.23

1.4

2.7

1.46

1.52

mmol/l

—

(3025941) Bacteria identified in Stool by Culture

157

0.82

0.23

1.5

1.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1.26

0.23

1.3

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

0.75

0.22

1.4

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

0.75

0.22

1.4

1.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

191

1.16

0.22

2.9

2.3

7.21

9.23

iu/l

0.46

141

(3002256) Pathology report gross observation

220

0.86

0.22

1.1

1.2

—

(3035941) MCH [Entitic mass]

315

3183

0.88

0.22

20.5

15.5

29.51

29.53

0.06

309

3128

(3024731) MCV [Entitic volume]

315

3183

0.88

0.22

20.5

15.5

88.30

88.26

0.05

309

3128

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

107

1.22

0.22

1.3

1.7

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.3

—

58.82

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.00

0.21

0.0

1.7

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

0.00

0.21

0.0

1.7

—

263.00

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.8

—

115.68

—

(3044927) Protein electrophoresis panel - Urine

0.00

0.21

0.0

1.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

0.21

0.0

1.6

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.00

0.21

0.0

3.2

—

(3006653) Thiamine [Moles/volume] in Blood

0.00

0.21

0.0

1.2

—

107.80

—

(3037756) Immunofixation for Serum or Plasma

0.00

0.21

0.0

1.6

—

(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.8

—

34.08

—

(3033882) Carnitine [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.7

—

40.08

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.00

0.21

0.0

1.5

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.00

0.21

0.0

1.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

1.17

0.21

1.2

1.7

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

0.00

0.21

0.0

1.2

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

2.1

—

1.24

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

0.00

0.21

0.0

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

0.00

0.21

0.0

1.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

0.00

0.21

0.0

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

0.20

0.0

2.0

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.20

0.0

2.6

—

1.45

—

(3006462) Nitrate [Presence] in Urine

0.00

0.20

0.0

2.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

395

0.90

0.20

1.2

15.15

19.46

iu/ml

0.39

104

(3020682) Albumin/Creatinine [Ratio] in Urine

424

1.10

0.20

3.9

4.4

7.28

12.71

mg/mmol

0.66

301

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

154

0.84

0.19

2.8

3.1

0.81

0.84

ug/l

—

105

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

206

2011

1.06

0.19

3.4

4.48

mmol/l

0.01

196

1900

(3009214) Lutropin [Units/volume] in Serum or Plasma

227

0.87

0.18

3.3

2.2

6.55

6.87

u/l

0.08

167

(3007461) Platelets [#/volume] in Blood

315

3179

0.90

0.18

20.5

15.6

271.44

263.44

e9/l

1.39

304

3074

(3015377) Calcium [Moles/volume] in Serum or Plasma

710

0.93

0.18

4.3

2.8

2.36

2.37

mmol/l

0.36

631

(3002523) Influenza virus A Ag [Presence] in Specimen

1.17

0.18

1.0

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

1.17

0.18

1.0

1.2

—

(3037121) Protein [Mass/volume] in Urine

131

0.83

0.17

2.4

5.5

0.14

0.28

g/l

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1.11

0.17

2.9

1.5

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

321

1.10

0.17

12.4

6.1

1.43

1.11

mmol/l

0.27

237

(3022145) Colonoscopy Study observation

204

0.88

0.16

1.3

1.4

—

(40760892) CBC W Ordered Manual Differential panel - Blood

145

1408

1.05

0.15

11.3

8.0

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1.16

0.15

1.7

1.6

41.44

34.45

u/l

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1.19

0.14

2.0

2.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

0.77

0.14

1.4

1.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

160

1.13

0.14

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

356

0.92

0.14

1.4

1.7

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

286

1.09

0.14

1.4

1.8

—

(3050129) First trimester maternal screen panel - Serum or Plasma

228

1.10

0.13

1.5

1.3

—

(3022096) Basophils/100 leukocytes in Blood

141

1373

1.05

0.13

10.3

7.9

0.63

0.64

0.04

130

1296

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

277

1.09

0.13

1.4

1.3

53.80

137.53

iu/ml

1.68

102

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1.18

0.13

1.6

1.4

0.09

0.01

iu/ml

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

375

0.93

0.13

1.1

1.2

20.34

7.49

u/ml

0.29

134

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

158

0.88

0.12

1.1

1.2

—

29.02

—

(3023520) Reticulocytes [#/volume] in Blood

220

0.90

0.12

5.3

4.0

60.49

65.73

e9/l

0.23

164

(3013707) Erythrocyte sedimentation rate by Westergren method

184

1875

0.96

0.12

4.8

4.1

8.83

8.71

mm/h

0.06

174

1716

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

124

1.13

0.11

1.7

2.0

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

153

1.12

0.11

1.0

1.1

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

633

1.05

0.11

4.7

3.3

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

616

0.95

0.11

2.4

2.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

212

1.09

0.10

1.3

—

(3044640) Blood type and Crossmatch panel - Blood

724

1.05

0.10

2.7

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

1.14

0.10

3.6

1.88

1.64

umol/l

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

745

1.04

0.09

1.6

1.7

—

(3028626) Oxygen [Partial pressure] in Capillary blood

262

1.07

0.09

8.0

6.2

10.05

9.82

kpa

0.26

255

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1.11

0.09

1.2

1.6

9.88

9.62

u/l

—

(3028300) Cannabinoids [Presence] in Urine

358

0.94

0.08

1.4

1.7

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1.10

0.08

1.1

1.3

—

2.00

—

(3018418) pH of Serum or Plasma

599

1.04

0.08

3.8

3.9

7.38

7.40

—

121

(3044290) Cell count panel - Cerebral spinal fluid

1.08

0.08

2.9

3.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1.08

0.08

1.1

1.3

—

11.16

—

(3027008) Opiates [Presence] in Urine

357

0.95

0.07

1.4

1.7

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

1.04

0.07

1.1

1.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.86

0.07

1.0

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.87

0.07

1.1

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

344

1.05

0.07

2.8

3.2

357.95

417.22

ng/l

0.08

197

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.85

0.07

2.0

1.3

—

(40761511) CBC panel - Blood by Automated count

291

2892

1.04

0.06

12.2

9.0

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

274

2723

1.03

0.05

10.7

8.5

25.22

24.31

u/l

0.21

262

2615

(3019069) Monocytes/100 leukocytes in Blood

145

1431

1.02

0.05

10.9

7.9

8.37

8.31

0.07

134

1358

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

100

1.10

0.05

1.9

2.3

28.91

45.03

u/ml

0.36

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

161

0.93

0.05

2.1

1.6

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

161

0.93

0.05

1.5

1.3

239.91

290.79

miu/ml

—

(3027944) Amphetamines [Presence] in Urine

353

0.96

0.05

1.4

1.7

—

(3012516) Albumin [Mass/volume] in Urine

407

1.04

0.04

2.8

3.7

61.54

85.10

mg/l

0.25

290

(3002030) Lymphocytes/100 leukocytes in Blood

152

1503

1.02

0.04

10.7

7.5

32.32

32.10

0.10

142

1433

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

299

1.04

0.04

2.3

2.6

2.43

mmol/l

0.10

254

(3023103) Potassium [Moles/volume] in Serum or Plasma

255

2564

0.98

0.04

16.3

11.7

3.92

3.89

mmol/l

0.81

242

2473

(3017143) Hepatitis C virus Ab [Presence] in Serum

459

1.03

0.03

1.6

1.5

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

122

1233

0.98

0.03

2.0

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

519

1.03

0.03

2.2

1.9

—

(3016879) Cocaine [Presence] in Urine

330

1.03

0.03

1.4

1.7

—

(3006504) Eosinophils/100 leukocytes in Blood

143

1417

1.02

0.03

10.5

7.7

3.19

2.84

1.02

132

1338

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

252

2532

0.98

0.03

4.8

4.2

1.89

1.90

mu/l

0.02

240

2345

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

879

1.02

0.02

3.4

3.9

—

(3037522) Nuclear Ab [Titer] in Serum

361

1.03

0.02

1.5

573.33

562.42

titre

—

(4200892) Spirometry reversibility

153

1.05

0.01

1.2

1.5

—

(3018010) Neutrophils/100 leukocytes in Blood

148

1471

1.01

0.01

10.4

7.3

53.23

53.60

0.16

139

1399

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

200

2007

0.99

0.01

10.2

8.8

95.73

99.82

ml/min/173m2

1.13

140

1437

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

114

1.05

0.00

1.3

1.4

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

256

2566

0.99

0.00

16.4

11.7

139.43

139.57

mmol/l

0.42

245

2481

(3020630) Protein [Mass/volume] in Serum or Plasma

112

0.98

0.00

1.8

2.9

68.45

64.55

g/l

1.32

106

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

572

1.00

0.00

2.9

2.6

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1.03

0.00

1.5

1.8

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

145

0.96

0.00

4.5

3.1

60.20

79.32

ml/min/173m2

—

(3022313) Gas panel - Capillary blood

266

1.02

0.00

8.0

6.6

—

(3036048) Francisella tularensis Ab [Titer] in Serum

0.00

0.0

1.0

—

(3017509) Phencyclidine [Presence] in Urine

0.00

0.0

1.2

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

0.00

0.0

6.9

—

(3051593) INR in Capillary blood by Coagulation assay

0.00

0.0

21.0

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3012565) Volume of 24 hour Urine

0.00

0.0

1.4

—

2005.56

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

0.00

0.0

3.6

—

57.30

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

0.00

0.0

2.2

—

9.78

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

0.00

0.0

1.0

—

(3014271) Vancomycin [Susceptibility]

0.00

0.0

2.6

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

0.00

0.0

28.0

—

0.58

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

0.00

0.0

1.2

—

85.51

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

0.00

0.0

1.5

—

58.48

—

(3017704) Immunofixation for Urine

0.00

0.0

1.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.2

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.00

0.0

1.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

0.00

0.0

1.3

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

0.00

0.0

9.1

—

(3001556) Androgen free Index in Serum or Plasma

0.00

0.0

1.0

—

(3001186) Copper [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

16.40

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

47.14

—

(3013727) Leukocytes other/100 leukocytes in Blood

0.00

-0.00

0.0

13.1

—

59.31

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

0.91

-0.00

1.4

1.6

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

-0.00

0.0

3.4

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

17.43

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

0.98

-0.00

1.4

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

-0.00

0.0

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.00

-0.00

0.0

1.0

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

207

2070

1.00

-0.00

3.4

3.1

5.49

5.58

mmol/l

0.56

196

1890

(3004588) Protein electrophoresis panel - Serum or Plasma

1.00

-0.00

1.0

2.2

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

0.94

-0.00

1.2

1.5

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.92

-0.00

9.5

9.3

—

110.00

—

(1616796) Gas panel - Central venous blood

0.94

-0.00

2.2

5.0

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.00

-0.00

0.0

1.4

—

(3049233) Organic acids panel - Urine

0.00

-0.00

0.0

1.1

—

(3031040) Bacteria [#/volume] in Urine by Automated count

174

1740

1.00

-0.00

4.7

4.1

297.83

229.59

e6/l

—

(3013336) Amino acids [Identifier] in Serum or Plasma

0.00

-0.00

0.0

3.0

—

(3020650) Glucose [Presence] in Urine

0.00

-0.00

0.0

1.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

180

1.00

-0.00

2.8

2.7

—

(3032641) Amino acids panel - Urine

0.00

-0.00

0.0

1.3

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

180

1.00

-0.00

1.6

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

1.9

—

10.86

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

1.63

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

0.00

-0.00

0.0

1.9

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

0.00

-0.00

0.0

1.4

—

312.66

—

Mortality – FinRegistry

↥

Association

Association between endpoint K11_MAXIL_CANINE_FAILED_ERUPT_OBSTRUCTION_TOOTH and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have K11_MAXIL_CANINE_FAILED_ERUPT_OBSTRUCTION_TOOTH.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: K11_MAXIL_CANINE_FAILED_ERUPT_OBSTRUCTION_TOOTH – Impacted maxillary canine

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Impacted maxillary canine

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints